20-HETE
Selleck Chemicals
SKU:E5860
Couldn't load pickup availability

20-HETE is a metabolite-class compound relevant to cardiovascular and metabolism models. It is especially relevant in cardiovascular and metabolism models, where defined compound exposure can be linked to metabolite-dependent biochemical and phenotypic responses. Dose-response comparison, orthogonal validation, and secondary assay follow-up can further sharpen mechanistic interpretation.
As a metabolite-class reagent, 20-HETE is applicable to studies of metabolite-dependent phenotype changes, biochemical conversion, and pathway-context effects. That positioning is consistent with metabolite supplementation and biochemical reference studies and with follow-up studies that compare concentration-dependent responses across orthogonal assay formats. In cardiovascular and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Metabolite supplementation and biochemical reference studies
- Phenotypic profiling in cardiovascular and metabolism models
- Combination studies with orthogonal perturbagens
- Mechanism-oriented follow-up using biochemical and cellular endpoints
Overall, 20-HETE is appropriate for studies that compare metabolite-dependent biochemical and phenotypic responses in cardiovascular and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Research Area:
- Cardiovascular • Metabolism
- CAS No.:
- 79551-86-3
- Molecular Weight:
- 326.50
- Formula:
- C₂₀H₂₆D₆O₃
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.